Skip to content

Topical Menthol For Tear Secretion

Topical Menthol for Tear Secretion

Status
Enrolling by invitation
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07109609
Acronym
TMTS
Enrollment
30
Registered
2025-08-07
Start date
2025-08-17
Completion date
2025-12-01
Last updated
2025-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dry Eyes, Healthy

Keywords

tear secretion, dry eyes, eye drops, menthol, vapor, cornea

Brief summary

Tears are the natural way to keep eyes moist, and tears are important for good vision and healthy eyes. Eyes without enought tears get dry and sore. The natural and normal way to stimulate secretion of tears is by turning on cold sensors that are located on the cornea of the eye. Tear are normally released across the eyeball in a finely balanced system that balances out that natural evaporation. But sometimes there is not enough tear secretion to balance out the evaporation of tears and eyes can get sore. The aim here is to test whether menthol in its vapor form may possibly turn on those cold sensors and thus cause secretion of tears. Use of menthol vapors may be like having a switch to release more tears. The aim of this clinical trial is to test the hypothesis that a menthol solution applied onto a cheek will release enough menthol vapor into the air flowing up over the eye's cornea to stimulate cold sensors enough to make a tear flow from the eye. If the hypothesis that menthol safely stimulates tear secretion in healthy people proves to be correct, then this clinical trial may inspire more new research into the use of menthol as an alternative to the use of eye drops for some people.

Detailed description

This is a proof-of-principle clinical trial. It is a double-blind, placebo-controlled, randomized clinical trial. Participants are not being seen by a physician for eye disease, and there is a 50% probability that a participant will receive active treatment, or 50% probability that they will just receive the carrier oil with nothing in it (placebo).

Interventions

DRUGTopical application of 20% menthol solution in MCT oil.

To facilitate reproducible and correct application of the solution, the subject wears glasses while the product is applied. The solution is rolled onto one cheek by rolling it to an area of about 2cm X 2cm at the cheekbone, underneath the bottom rim of the glasses worn. This method delivers about 12 mg solution, i.e. 2.4 mg menthol to one cheek. Or this method delviers 12 mg of placebo oil. The subject then sits in still air for 5 minutes, at which point tissue is wiped across the skin below the bottom eyelashes to permit the weighing of secreted tear.

DRUGTopical Placebo Oil rolled onto the cheek.

To facilitate reproducible and correct application of the Placebo oil, the subject wears glasses while the product is applied. The Placebo oil is rolled onto one cheek by rolling it to an area of about 2cm X 2cm at the cheekbone, underneath the bottom rim of the glasses worn. This method delivers zero active agent. The subject then sits in still air for 5 minutes, at which point tissue is wiped across the skin below the bottom eyelashes to permit the weighing of secreted tear.

Sponsors

Stearacl Inc
CollaboratorINDUSTRY
Reinhold Vieth
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Not under care of an opthalmologist for treatment of dry-eyes

Exclusion criteria

* • Excluded if Yes to any of the questions below. * Are you allergic to menthol or to menthol-containing products like tooth paste or certain cold remedies? * Are you wearing contact lenses during the time of testing? \_\_\_\_\_\_\_\_ * Are there tears present prior to applying the menthol? \_\_\_\_\_\_\_\_ * Did you use of eye drops during the hour before participation? \_\_\_\_\_\_\_\_ * Do you have broken, irritated, sensitive skin and/or acne at or around application site? \_\_\_\_\_\_\_\_ * Do you have a history of atopy, allergic diseases at the skin of your cheeks? * Do you have Stevens-Johnson syndrome, which is any known skin response to chemical, thermal, or radiation injury to the application area? \_\_\_\_

Design outcomes

Primary

MeasureTime frameDescription
Weight of nasal secretion blown into tissue.Within 10 minutes of applying the dose.The purpose is to test whether there is evidence of shared innervation of TRPM8 receptors (the menthol-responsive sensors for cold) in cornea and nasal subepithelium. The particpant holds closed the left nostril, while blowing into a tissue from the right nostril. The increase in weight of tissue is measured.
Objective measure of tear stimulation Yes or NoParticipant is observed for 5 minutes after application, to record tear-weight data, and the related questions that are asked are completed within 10 minutes after applicaiton.The outcome is the binary yes/no observation of active tear secretion that overflows to the skin below the bottom eyelashes. Subject sits in still air while wearing glasses to ensure correct positioning of the topical application. The solution of menthol or placebo is dispensed from a roller-ball bottle to the right eye only, onto an area about 2cm x 2 cm just below the bottom rim of the glasses; that is, inferior to the pupil, and in line with the bottom of the nose. Within 5 minutes of sitting in still air, If moisture is evident below the bottom eyelashes, glasses are removed and tissue is dabbed, or wiped under bottom eyelash to take up the tear. If that wipe increases the weight of the tissue by at least 6 milligrams, then a Yes response is recorded. If after 5 minutes a wipe of tissue across the bottom eyelashes of the right eye does not increase the weight of tissue by at least 6 milligrams, a No is recorded to indicate that there was no increase in tear secretion.
Weight of tearMeasured at 5 minutes after dose application.The actual measured weight of the tear(s) collected onto the tissue, from below the right eye.
Was there a subjective difference between left and right eyes in terms of sense if moisture5 to 10 minutes after applicationResponse to the question: Which eye feels more moist? Left eye more moist or No difference (both same) or ….Right eye more moist

Secondary

MeasureTime frameDescription
Weight of nasal secretion5 to 10 minutes after applicationSubject blows their nose into a tissue, and the increase in tissue weight is recorded.
Discomfortable feeling at the treated eye.10 minutesAt your right eye, was there anything uncomfortable feeling? Nothing mild moderate severe (choose one)
Degree of cooling or pain at the skin where the dose was applied.10 minutesAt the skin of the cheek, where it was rolled on, did you feel (choose one) COOLING OR NOTHING OR PAIN If cooling or pain, how strong was the feeling? (choose one) Nothing mild moderate severe
Did the procedure increase sense of runny nose?10 minutesDid you feel a runny nose, or nasal secretion during the 5 minutes of waiting? No or Yes And if Yes, at which nostril? Left or Right or Both nostrils

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026